Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients
Mar 24, 2020 | Featured, Infectious Diseases, Research |
The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it.
The process of using antibody-rich plasma from COVID-19 patients to help others was used successfully in China, according to a state-owned organization, which reported that some patients improved within 24 hours, with reduced inflammation and viral loads, and better oxygen levels in the blood.
Read more: https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/?fbclid=IwAR06MRKSUuQw-WSvHGLsVJtqgHEOJa8Kw9kY9uGcEU5yK56zw95BI_KeKag#.XnvuzfkUx5J.facebook
Dr. A Mathew MPT, DPT
We strongly believe that everyone should have a clear understanding of what's going on with their body rather that relying on medical professionals for every little thing.
1605 Hillside Ave,
New Hyde Park, NY 11040
We are open
Mon - Fri: 7:00 am - 10:00 pm
Saturday: 9:00 am - 5:00 pm
Sunday: 12:00 pm - 7:00 pm